MetaADEDB 2.0 @ LMMD
Methamphetamine
(TWXDDNPPQUTEOV-FVGYRXGTSA-N)
Structure
SMILES
CN[C@H](Cc1ccccc1)C.Cl
Molecular Formula:
C10H16ClN
Molecular Weight:
185.694
Log P:
3.0299
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
2
TPSA:
12.03
CAS Number(s):
51-57-0
Synonym(s)
1.
Methamphetamine
2.
Deoxyephedrine
3.
Desoxyephedrine
4.
Desoxyn
5.
Madrine
6.
Metamfetamine
7.
Methamphetamine Hydrochloride
8.
Methylamphetamine
9.
N-Methylamphetamine
10.
Hydrochloride, Methamphetamine
11.
N Methylamphetamine
External Link(s)
MeSHD008694
PubChem Compound6857544
66124
ChEBI35340
CHEMBLCHEMBL1200952
KEGGdr:D02242
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug abuserFAERS: 35US FAERS
2Drug toxicityFAERS: 28US FAERS
3Intentional misuseFAERS: 19US FAERS
4Drug ineffectiveFAERS: 10US FAERS
5Pulmonary HypertensionFAERS: 9US FAERS
6nervous system disorderFAERS: 9US FAERS
7Acute Coronary SyndromeFAERS: 8US FAERS
8Blood creatine phosphokinase increasedFAERS: 7US FAERS
9Cardiac ArrestFAERS: 7US FAERS
10Ejection Fraction DecreasedFAERS: 7US FAERS
11Completed SuicideFAERS: 5US FAERS
12Drug screen positiveFAERS: 5US FAERS
13Intentional drug misuseFAERS: 5US FAERS
14Respiratory arrestFAERS: 5US FAERS
15Blood creatine phosphokinase MB increasedFAERS: 4US FAERS
16ChoreoathetosisFAERS: 4US FAERS
17Myocardial InfarctionFAERS: 4US FAERS
18OverdoseFAERS: 4US FAERS
19Troponin I increasedFAERS: 4US FAERS
20Abdominal PainFAERS: 3US FAERS
21ApoptosisFAERS: 3US FAERS
22Myocardial fibrosisFAERS: 3US FAERS
23Product substitution issueFAERS: 3US FAERS
24AgitationFAERS: 2US FAERS
25AnxietyFAERS: 2US FAERS
26AstheniaFAERS: 2US FAERS
27Brain HypoxiaFAERS: 2US FAERS
28Cardiac HypertrophyFAERS: 2US FAERS
29CardiomegalyFAERS: 2US FAERS
30Cerebrovascular accidentFAERS: 2US FAERS
31Chest PainFAERS: 2US FAERS
32DisorientationFAERS: 2US FAERS
33FatigueFAERS: 2US FAERS
34Foreign body traumaFAERS: 2US FAERS
35HeadacheFAERS: 2US FAERS
36InfectionFAERS: 2US FAERS
37InflammationFAERS: 2US FAERS
38Intestinal infarctionFAERS: 2US FAERS
39MalaiseFAERS: 2US FAERS
40Obsessive-Compulsive DisorderFAERS: 2US FAERS
41PseudovasculitisFAERS: 2US FAERS
42Renal tubular disorderFAERS: 2US FAERS
43Self MutilationFAERS: 2US FAERS
44Toxicologic test abnormalFAERS: 2US FAERS
45TremorFAERS: 2US FAERS
46Venous stasisFAERS: 2US FAERS
47Abdominal tendernessFAERS: 1US FAERS
48Acute myocardial infarctionFAERS: 1US FAERS
49Alanine Aminotransferase IncreasedFAERS: 1US FAERS
50AmnesiaFAERS: 1US FAERS
51AnorexiaFAERS: 1US FAERS
52Arterial InjuryFAERS: 1US FAERS
53ArthralgiaFAERS: 1US FAERS
54Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
55AtherosclerosisFAERS: 1US FAERS
56Back PainFAERS: 1US FAERS
57Band neutrophil percentage increasedFAERS: 1US FAERS
58BedriddenFAERS: 1US FAERS
59Blood alkaline phosphatase increasedFAERS: 1US FAERS
60Blood cannabinoidsFAERS: 1US FAERS
61Blood creatine increasedFAERS: 1US FAERS
62Blood glucose decreasedFAERS: 1US FAERS
63Blood pH decreasedFAERS: 1US FAERS
64Blood pressure inadequately controlledFAERS: 1US FAERS
65Blood sodium increasedFAERS: 1US FAERS
66Blood urea increasedFAERS: 1US FAERS
67BradycardiaFAERS: 1US FAERS
68BruxismFAERS: 1US FAERS
69Cardiac ventricular thrombosisFAERS: 1US FAERS
70CardiotoxicityFAERS: 1US FAERS
71ChillsFAERS: 1US FAERS
72ConstipationFAERS: 1US FAERS
73Coronary Artery DiseaseFAERS: 1US FAERS
74CyanosisFAERS: 1US FAERS
75Cyclothymic DisorderFAERS: 1US FAERS
76DeafnessFAERS: 1US FAERS
77Deep Vein ThrombosisFAERS: 1US FAERS
78Depressed Level of ConsciousnessFAERS: 1US FAERS
79Depressed moodFAERS: 1US FAERS
80Depression suicidalFAERS: 1US FAERS
81DizzinessFAERS: 1US FAERS
82DrowningFAERS: 1US FAERS
83Drug withdrawal syndromeFAERS: 1US FAERS
84DysarthriaFAERS: 1US FAERS
85DysuriaFAERS: 1US FAERS
86Electrocardiogram T wave peakedFAERS: 1US FAERS
87Electrocardiogram changeFAERS: 1US FAERS
88Endocardial diseaseFAERS: 1US FAERS
89EndocarditisFAERS: 1US FAERS
90EosinophiliaFAERS: 1US FAERS
91ExsanguinationFAERS: 1US FAERS
92Feeling abnormalFAERS: 1US FAERS
93Hallucinations, mixedFAERS: 1US FAERS
94HyperphagiaFAERS: 1US FAERS
95Hypertensive crisisFAERS: 1US FAERS
96HypotensionFAERS: 1US FAERS
97HypoxiaFAERS: 1US FAERS
98Impaired work abilityFAERS: 1US FAERS
99Injury asphyxiationFAERS: 1US FAERS
100Joint swellingFAERS: 1US FAERS
101LethargyFAERS: 1US FAERS
102MenorrhagiaFAERS: 1US FAERS
103Multi-organ disorderFAERS: 1US FAERS
104NauseaFAERS: 1US FAERS
105Nephrotic SyndromeFAERS: 1US FAERS
106ObesityFAERS: 1US FAERS
107PCO2 increasedFAERS: 1US FAERS
108PO2 increasedFAERS: 1US FAERS
109PalpitationsFAERS: 1US FAERS
110Penile InfectionFAERS: 1US FAERS
111Penile swellingFAERS: 1US FAERS
112Performance status decreasedFAERS: 1US FAERS
113Post procedural complicationFAERS: 1US FAERS
114Product dose omissionFAERS: 1US FAERS
115Product formulation issueFAERS: 1US FAERS
116Product use in unapproved indicationFAERS: 1US FAERS
117Product use issueFAERS: 1US FAERS
118Pulmonary EmbolismFAERS: 1US FAERS
119Pulmonary congestionFAERS: 1US FAERS
120Renal tubular necrosisFAERS: 1US FAERS
121Respiratory FailureFAERS: 1US FAERS
122Retinopathy of PrematurityFAERS: 1US FAERS
123RhabdomyolysisFAERS: 1US FAERS
124Seizure like phenomenaFAERS: 1US FAERS
125Septic ShockFAERS: 1US FAERS
126ShockFAERS: 1US FAERS
127Sinus TachycardiaFAERS: 1US FAERS
128SomnolenceFAERS: 1US FAERS
129StuporFAERS: 1US FAERS
130Supraventricular tachycardiaFAERS: 1US FAERS
131ThrombosisFAERS: 1US FAERS
132Toxicity to various agentsFAERS: 1US FAERS
133Urethral fistulaFAERS: 1US FAERS
134Venous InjuryFAERS: 1US FAERS
135Ventricular hypokinesiaFAERS: 1US FAERS
136VomitingFAERS: 1US FAERS
137Weight decreasedFAERS: 1US FAERS
138White blood cell count decreasedFAERS: 1US FAERS
139treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.